Protein showing enhanced expression in cancer cells
View Patent ↗A novel gene (designated 101P3A11 or PHOR-1) and its encoded protein, and variants thereof, are described wherein 101P3A11 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 101P3A11 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 101P3A11 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 101P3A11 can be used in active or passive immunization.
1. An isolated 101P3A11 (PHOR 1) v.1 protein that comprises the amino acid sequence of SEQ ID NO: 28.
2. The protein of claim 1 , which further comprises a label.
3. An isolated 101P3A11 (PHOR 1) v.1 protein that consists of the amino acid sequence of SEQ ID NO: 28.
4. The protein of claim 3 , which further comprises a label.
5. An isolated 101P3A11 (PHOR 1) v.1 protein, which is encoded by the cDNA contained in plasmid 101P3A11 deposited with the American Type Culture Collection (ATCC) as Accession No. PTA312.
6. The protein of claim 5 , which further comprises a label.